Biomarker Discovery Project in High Grade Serous Ovarian Cancer

Status: Recruiting
Location: See all (7) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a sample study that will collect biological samples (blood, tumor tissue, ascites, and/or other fluids) from gynecological cancer patients for biomarker research. In addition, the results of the testing done on the samples will be given to the participant's treating physician who may use the information to guide treatment decisions.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Histological diagnosis of stage III or IV high grade serous ovarian, tubal or primary peritoneal cancer.

• Must be 18 years of age or older.

• Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1.

• Have a life expectancy greater than or equal to 6 months.

• Able to provide adequate informed consent.

• Willing to undergo blood or fluid collection and tumour biopsy

• Patients enrolled at the time of surgery must agree to have part of their tumour used for the purpose of the study.

• Archival tissue must be available for patients that are enrolled at the time of progression.

Locations
Other Locations
Canada
Royal Victoria Regional Health Centre
RECRUITING
Barrie
Juravinski Cancer Centre
ACTIVE_NOT_RECRUITING
Hamilton
Kingston Health Sciences Centre
RECRUITING
Kingston
London Health Sciences Centre
RECRUITING
London
The Ottawa Hospital Cancer Centre
RECRUITING
Ottawa
Princess Margaret Cancer Centre
RECRUITING
Toronto
Sunnybrook Health Sciences Centre
RECRUITING
Toronto
Contact Information
Primary
Amit Oza, M.D.
amit.oza@uhn.ca
416-946-2818
Time Frame
Start Date: 2018-01-08
Estimated Completion Date: 2026-06-08
Participants
Target number of participants: 510
Treatments
Experimental: Sample Collection
The following samples may be collected during the study:~* Tumour tissue samples~* Blood samples~* Ascites samples~* Other fluids requiring drainage
Related Therapeutic Areas
Sponsors
Leads: University Health Network, Toronto

This content was sourced from clinicaltrials.gov

Similar Clinical Trials